Yoshimura, T.; Higashi, S.; Yamada, S.; Noguchi, H.; Nomoto, M.; Suzuki, H.; Ishida, T.; Takayama, H.; Hirano, Y.; Yamashita, M.;
et al. PCP4/PEP19 and HER2 Are Novel Prognostic Markers in Mucoepidermoid Carcinoma of the Salivary Gland. Cancers 2022, 14, 54.
https://doi.org/10.3390/cancers14010054
AMA Style
Yoshimura T, Higashi S, Yamada S, Noguchi H, Nomoto M, Suzuki H, Ishida T, Takayama H, Hirano Y, Yamashita M,
et al. PCP4/PEP19 and HER2 Are Novel Prognostic Markers in Mucoepidermoid Carcinoma of the Salivary Gland. Cancers. 2022; 14(1):54.
https://doi.org/10.3390/cancers14010054
Chicago/Turabian Style
Yoshimura, Takuya, Shotaro Higashi, Sohsuke Yamada, Hirotsugu Noguchi, Mitsuharu Nomoto, Hajime Suzuki, Takayuki Ishida, Hirotaka Takayama, Yuka Hirano, Masaru Yamashita,
and et al. 2022. "PCP4/PEP19 and HER2 Are Novel Prognostic Markers in Mucoepidermoid Carcinoma of the Salivary Gland" Cancers 14, no. 1: 54.
https://doi.org/10.3390/cancers14010054
APA Style
Yoshimura, T., Higashi, S., Yamada, S., Noguchi, H., Nomoto, M., Suzuki, H., Ishida, T., Takayama, H., Hirano, Y., Yamashita, M., Tanimoto, A., & Nakamura, N.
(2022). PCP4/PEP19 and HER2 Are Novel Prognostic Markers in Mucoepidermoid Carcinoma of the Salivary Gland. Cancers, 14(1), 54.
https://doi.org/10.3390/cancers14010054
